Delhi High Court Directs NPPA Not to Take Coercive Steps
The Delhi High Court directed India’s National Pharmaceutical Pricing Authority not to take coercive steps against AstraZeneca Pharma India.
Related stories
Konan Technology Faces One-Month Public-Sector Bidding Ban
Konan Technology faces a one-month ban on bidding for public-sector contracts.
L impact | REGULATION | Nov 02, 2026, 07:27 AM UTC
Konan Technology Barred From Government Bidding for One Month
Konan Technology is barred from bidding with government and public institutions from Nov. 23 to Dec. 22, 2026, as a penalty for improper conduct.
M impact | REGULATION | Nov 02, 2026, 07:27 AM UTC
Bulgaria’s incumbent president wins runoff, vote count shows
Reuters reports that Bulgaria’s incumbent president has won the runoff, according to the vote count.
L impact | REGULATION | Nov 02, 2026, 07:10 AM UTC
South Korea Urges Crypto Exchanges to Tighten Security
South Korea's financial regulator urged local cryptocurrency exchanges to strengthen security measures against hacking, following a $6.3 billion theft at Binance last week.
L impact | REGULATION | Nov 02, 2026, 06:56 AM UTC
India Markets Regulator Backs Removing Long-Term Capital Gains Tax for Foreign Investors
India’s markets regulator backs removing the long-term capital gains tax for foreign investors, according to sources.
L impact | REGULATION | Nov 02, 2026, 06:35 AM UTC
Indian Pricing Authority Barred From Recovering 1.51 Billion Rupees Until Next Hearing
L impact | REGULATION | Nov 02, 2026, 06:24 AM UTC